Funding for this research was provided by:
Chonnam National University Hospital Biomedical Research Institute (BCRI20072)
Received: 14 March 2019
Accepted: 27 March 2020
First Online: 15 April 2020
Ethics approval and consent to participate
: This case-series study included the off-label ophthalmic applications of EGF, and was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and with approval from the Institutional Review Board at the Chonnam National University Hospital (IRB approval number: CNUH-2019-094). Written informed consent was obtained from each patient before enrollment.
: We did not obtain consent since this study did not contain any individually identifiable data.
: The authors declare that they have no competing interests.